Global Pediatrics Respiratory Drugs Market
Global Pediatrics Respiratory Drugs Market

Pediatrics Respiratory Drugs Comprehensive Study by Disease Type (Asthma, Cystic Fibrosis, Bronchiolitis, Pneumonia, Tuberculosis, Others), Distribution Channel (Hospitals & Clinics, Retail Pharmacies, Online Pharmacies), Form (Tablets, Powder, Injection, Others), Drug Class (Anti-Inflammatory Drugs, Bronchodilators, Combination Drugs, Corticosteroid, Monoclonal Antibodies, Others) Players and Region - Global Market Outlook to 2026

Pediatrics Respiratory Drugs Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Feb 2021 Edition 222 Pages 216 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Pediatrics Respiratory Drugs Market Scope?
Respiratory diseases are pathological conditions affecting the organs and tissues that make gas exchange difficult during breathing. Respiratory disorders in infants and children are challenging problems for every clinician involved in the management of these patients. Before the rising prevalence of respiratory diseases in pediatrics has been the key factor for the growth of the pediatrics respiratory drugs market. Progressive increase in the obese pediatric population, changing lifestyle habits, and a surge in awareness about pediatric care are anticipated to increase expenditure on pediatric respiratory disease treatment, and this resulted in the growth of the global pediatrics respiratory drugs market in the forecast period.

The Pediatrics Respiratory Drugs market study is being classified and major geographies with country level break-up.

Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Pediatrics Respiratory Drugs market throughout the predicted period.

Abbott Laboratories (United States), Bayer (Germany), Eli Lilly (United States), Forest Laboratories (United States), AstraZeneca plc (United Kingdom), GlaxoSmithKline (United Kingdom), Johnson & Johnson (United States), Novartis Pharmaceuticals (Switzerland), Novo Nordisk (Denmark), Merck (United States) and Pfizer (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are F. Hoffmann-La Roche AG (Switzerland), Regeneron Pharmaceuticals (United States), Boehringer Ingelheim (Germany), MedImmune (United States), Zambon (Italy), Genentech (United States), Colgate Oral Pharmaceuticals (United States) and Bristol-Myers Squibb (United States).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Pediatrics Respiratory Drugs market by Type, Application and Region.

On the basis of geography, the market of Pediatrics Respiratory Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their development strategies
On 25th July 2019, Zambon has announced the acquisition of Breath Therapeutics and its subsidiaries for euro 140 million (up to a total euro 500 million subject to regulatory and sales milestones). This combination will improve both companiesí ability to better serve patients and healthcare professionals in severe respiratory diseases, as well as accelerate the commercialization of these important new therapies.
On 28th September 2020, Pfizer Inc. has announced that the United States (U.S.) Food and Drug Administration (FDA) approved XELJANZ (tofacitinib) for the treatment of children and adolescents 2 years and older with active polyarticular course juvenile idiopathic arthritis (pcJIA). Two formulations were approved, a tablet and an oral solution, and are dosed based upon weight.


Influencing Market Trend
  • Rise in Awareness about Pediatric Care

Market Drivers
  • Rising Prevalence of Chronic Respiratory Diseases in Pediatric
  • Progressive Increase in Obese Pediatric Population
  • Government and Non-government Organizations Focus on Campaigns to Increase Awareness about Pediatric Health

Opportunities
  • Increasing Research and Development in Drug Discovery for Respiratory Diseases

Restraints
  • Stringent Regulations for Drug Approval

Challenges
  • Side Effects from Therapeutic drugs


Key Target Audience
Pediatrics Respiratory Drugs Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.
Report Objectives / Segmentation Covered
By Disease Type
  • Asthma
  • Cystic Fibrosis
  • Bronchiolitis
  • Pneumonia
  • Tuberculosis
  • Others

By Distribution Channel
  • Hospitals & Clinics
  • Retail Pharmacies
  • Online Pharmacies

By Form
  • Tablets
  • Powder
  • Injection
  • Others

By Drug Class
  • Anti-Inflammatory Drugs
  • Bronchodilators
  • Combination Drugs
  • Corticosteroid
  • Monoclonal Antibodies
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Chronic Respiratory Diseases in Pediatric
      • 3.2.2. Progressive Increase in Obese Pediatric Population
      • 3.2.3. Government and Non-government Organizations Focus on Campaigns to Increase Awareness about Pediatric Health
    • 3.3. Market Challenges
      • 3.3.1. Side Effects from Therapeutic drugs
    • 3.4. Market Trends
      • 3.4.1. Rise in Awareness about Pediatric Care
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pediatrics Respiratory Drugs, by Disease Type, Distribution Channel, Form, Drug Class and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Pediatrics Respiratory Drugs (Value)
      • 5.2.1. Global Pediatrics Respiratory Drugs by: Disease Type (Value)
        • 5.2.1.1. Asthma
        • 5.2.1.2. Cystic Fibrosis
        • 5.2.1.3. Bronchiolitis
        • 5.2.1.4. Pneumonia
        • 5.2.1.5. Tuberculosis
        • 5.2.1.6. Others
      • 5.2.2. Global Pediatrics Respiratory Drugs by: Distribution Channel (Value)
        • 5.2.2.1. Hospitals & Clinics
        • 5.2.2.2. Retail Pharmacies
        • 5.2.2.3. Online Pharmacies
      • 5.2.3. Global Pediatrics Respiratory Drugs by: Form (Value)
        • 5.2.3.1. Tablets
        • 5.2.3.2. Powder
        • 5.2.3.3. Injection
        • 5.2.3.4. Others
      • 5.2.4. Global Pediatrics Respiratory Drugs by: Drug Class (Value)
        • 5.2.4.1. Anti-Inflammatory Drugs
        • 5.2.4.2. Bronchodilators
        • 5.2.4.3. Combination Drugs
        • 5.2.4.4. Corticosteroid
        • 5.2.4.5. Monoclonal Antibodies
        • 5.2.4.6. Others
      • 5.2.5. Global Pediatrics Respiratory Drugs Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Pediatrics Respiratory Drugs (Volume)
      • 5.3.1. Global Pediatrics Respiratory Drugs by: Disease Type (Volume)
        • 5.3.1.1. Asthma
        • 5.3.1.2. Cystic Fibrosis
        • 5.3.1.3. Bronchiolitis
        • 5.3.1.4. Pneumonia
        • 5.3.1.5. Tuberculosis
        • 5.3.1.6. Others
      • 5.3.2. Global Pediatrics Respiratory Drugs by: Distribution Channel (Volume)
        • 5.3.2.1. Hospitals & Clinics
        • 5.3.2.2. Retail Pharmacies
        • 5.3.2.3. Online Pharmacies
      • 5.3.3. Global Pediatrics Respiratory Drugs by: Form (Volume)
        • 5.3.3.1. Tablets
        • 5.3.3.2. Powder
        • 5.3.3.3. Injection
        • 5.3.3.4. Others
      • 5.3.4. Global Pediatrics Respiratory Drugs by: Drug Class (Volume)
        • 5.3.4.1. Anti-Inflammatory Drugs
        • 5.3.4.2. Bronchodilators
        • 5.3.4.3. Combination Drugs
        • 5.3.4.4. Corticosteroid
        • 5.3.4.5. Monoclonal Antibodies
        • 5.3.4.6. Others
      • 5.3.5. Global Pediatrics Respiratory Drugs Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Pediatrics Respiratory Drugs (Price)
  • 6. Pediatrics Respiratory Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Eli Lilly (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Forest Laboratories (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. AstraZeneca plc (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GlaxoSmithKline (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Johnson & Johnson (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Novartis Pharmaceuticals (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Novo Nordisk (Denmark)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Merck (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Pfizer (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Pediatrics Respiratory Drugs Sale, by Disease Type, Distribution Channel, Form, Drug Class and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Pediatrics Respiratory Drugs (Value)
      • 7.2.1. Global Pediatrics Respiratory Drugs by: Disease Type (Value)
        • 7.2.1.1. Asthma
        • 7.2.1.2. Cystic Fibrosis
        • 7.2.1.3. Bronchiolitis
        • 7.2.1.4. Pneumonia
        • 7.2.1.5. Tuberculosis
        • 7.2.1.6. Others
      • 7.2.2. Global Pediatrics Respiratory Drugs by: Distribution Channel (Value)
        • 7.2.2.1. Hospitals & Clinics
        • 7.2.2.2. Retail Pharmacies
        • 7.2.2.3. Online Pharmacies
      • 7.2.3. Global Pediatrics Respiratory Drugs by: Form (Value)
        • 7.2.3.1. Tablets
        • 7.2.3.2. Powder
        • 7.2.3.3. Injection
        • 7.2.3.4. Others
      • 7.2.4. Global Pediatrics Respiratory Drugs by: Drug Class (Value)
        • 7.2.4.1. Anti-Inflammatory Drugs
        • 7.2.4.2. Bronchodilators
        • 7.2.4.3. Combination Drugs
        • 7.2.4.4. Corticosteroid
        • 7.2.4.5. Monoclonal Antibodies
        • 7.2.4.6. Others
      • 7.2.5. Global Pediatrics Respiratory Drugs Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Pediatrics Respiratory Drugs (Volume)
      • 7.3.1. Global Pediatrics Respiratory Drugs by: Disease Type (Volume)
        • 7.3.1.1. Asthma
        • 7.3.1.2. Cystic Fibrosis
        • 7.3.1.3. Bronchiolitis
        • 7.3.1.4. Pneumonia
        • 7.3.1.5. Tuberculosis
        • 7.3.1.6. Others
      • 7.3.2. Global Pediatrics Respiratory Drugs by: Distribution Channel (Volume)
        • 7.3.2.1. Hospitals & Clinics
        • 7.3.2.2. Retail Pharmacies
        • 7.3.2.3. Online Pharmacies
      • 7.3.3. Global Pediatrics Respiratory Drugs by: Form (Volume)
        • 7.3.3.1. Tablets
        • 7.3.3.2. Powder
        • 7.3.3.3. Injection
        • 7.3.3.4. Others
      • 7.3.4. Global Pediatrics Respiratory Drugs by: Drug Class (Volume)
        • 7.3.4.1. Anti-Inflammatory Drugs
        • 7.3.4.2. Bronchodilators
        • 7.3.4.3. Combination Drugs
        • 7.3.4.4. Corticosteroid
        • 7.3.4.5. Monoclonal Antibodies
        • 7.3.4.6. Others
      • 7.3.5. Global Pediatrics Respiratory Drugs Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Pediatrics Respiratory Drugs (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pediatrics Respiratory Drugs: by Disease Type(USD Million)
  • Table 2. Pediatrics Respiratory Drugs Asthma , by Region USD Million (2015-2020)
  • Table 3. Pediatrics Respiratory Drugs Cystic Fibrosis , by Region USD Million (2015-2020)
  • Table 4. Pediatrics Respiratory Drugs Bronchiolitis , by Region USD Million (2015-2020)
  • Table 5. Pediatrics Respiratory Drugs Pneumonia , by Region USD Million (2015-2020)
  • Table 6. Pediatrics Respiratory Drugs Tuberculosis , by Region USD Million (2015-2020)
  • Table 7. Pediatrics Respiratory Drugs Others , by Region USD Million (2015-2020)
  • Table 8. Pediatrics Respiratory Drugs: by Distribution Channel(USD Million)
  • Table 9. Pediatrics Respiratory Drugs Hospitals & Clinics , by Region USD Million (2015-2020)
  • Table 10. Pediatrics Respiratory Drugs Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 11. Pediatrics Respiratory Drugs Online Pharmacies , by Region USD Million (2015-2020)
  • Table 12. Pediatrics Respiratory Drugs: by Form(USD Million)
  • Table 13. Pediatrics Respiratory Drugs Tablets , by Region USD Million (2015-2020)
  • Table 14. Pediatrics Respiratory Drugs Powder , by Region USD Million (2015-2020)
  • Table 15. Pediatrics Respiratory Drugs Injection , by Region USD Million (2015-2020)
  • Table 16. Pediatrics Respiratory Drugs Others , by Region USD Million (2015-2020)
  • Table 17. Pediatrics Respiratory Drugs: by Drug Class(USD Million)
  • Table 18. Pediatrics Respiratory Drugs Anti-Inflammatory Drugs , by Region USD Million (2015-2020)
  • Table 19. Pediatrics Respiratory Drugs Bronchodilators , by Region USD Million (2015-2020)
  • Table 20. Pediatrics Respiratory Drugs Combination Drugs , by Region USD Million (2015-2020)
  • Table 21. Pediatrics Respiratory Drugs Corticosteroid , by Region USD Million (2015-2020)
  • Table 22. Pediatrics Respiratory Drugs Monoclonal Antibodies , by Region USD Million (2015-2020)
  • Table 23. Pediatrics Respiratory Drugs Others , by Region USD Million (2015-2020)
  • Table 24. South America Pediatrics Respiratory Drugs, by Country USD Million (2015-2020)
  • Table 25. South America Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 26. South America Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 27. South America Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 28. South America Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 29. Brazil Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 30. Brazil Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 31. Brazil Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 32. Brazil Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 33. Argentina Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 34. Argentina Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 35. Argentina Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 36. Argentina Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 37. Rest of South America Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 38. Rest of South America Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 39. Rest of South America Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 40. Rest of South America Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 41. Asia Pacific Pediatrics Respiratory Drugs, by Country USD Million (2015-2020)
  • Table 42. Asia Pacific Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 43. Asia Pacific Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 44. Asia Pacific Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 45. Asia Pacific Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 46. China Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 47. China Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 48. China Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 49. China Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 50. Japan Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 51. Japan Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 52. Japan Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 53. Japan Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 54. India Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 55. India Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 56. India Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 57. India Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 58. South Korea Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 59. South Korea Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 60. South Korea Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 61. South Korea Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 62. Taiwan Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 63. Taiwan Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 64. Taiwan Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 65. Taiwan Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 66. Australia Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 67. Australia Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 68. Australia Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 69. Australia Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 72. Rest of Asia-Pacific Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 73. Rest of Asia-Pacific Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 74. Europe Pediatrics Respiratory Drugs, by Country USD Million (2015-2020)
  • Table 75. Europe Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 76. Europe Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 77. Europe Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 78. Europe Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 79. Germany Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 80. Germany Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 81. Germany Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 82. Germany Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 83. France Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 84. France Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 85. France Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 86. France Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 87. Italy Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 88. Italy Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 89. Italy Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 90. Italy Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 91. United Kingdom Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 92. United Kingdom Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 93. United Kingdom Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 94. United Kingdom Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 95. Netherlands Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 96. Netherlands Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 97. Netherlands Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 98. Netherlands Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 99. Rest of Europe Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 100. Rest of Europe Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 101. Rest of Europe Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 102. Rest of Europe Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 103. MEA Pediatrics Respiratory Drugs, by Country USD Million (2015-2020)
  • Table 104. MEA Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 105. MEA Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 106. MEA Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 107. MEA Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 108. Middle East Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 109. Middle East Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 110. Middle East Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 111. Middle East Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 112. Africa Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 113. Africa Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 114. Africa Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 115. Africa Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 116. North America Pediatrics Respiratory Drugs, by Country USD Million (2015-2020)
  • Table 117. North America Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 118. North America Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 119. North America Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 120. North America Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 121. United States Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 122. United States Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 123. United States Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 124. United States Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 125. Canada Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 126. Canada Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 127. Canada Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 128. Canada Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 129. Mexico Pediatrics Respiratory Drugs, by Disease Type USD Million (2015-2020)
  • Table 130. Mexico Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 131. Mexico Pediatrics Respiratory Drugs, by Form USD Million (2015-2020)
  • Table 132. Mexico Pediatrics Respiratory Drugs, by Drug Class USD Million (2015-2020)
  • Table 133. Pediatrics Respiratory Drugs Sales: by Disease Type(Tonne)
  • Table 134. Pediatrics Respiratory Drugs Sales Asthma , by Region Tonne (2015-2020)
  • Table 135. Pediatrics Respiratory Drugs Sales Cystic Fibrosis , by Region Tonne (2015-2020)
  • Table 136. Pediatrics Respiratory Drugs Sales Bronchiolitis , by Region Tonne (2015-2020)
  • Table 137. Pediatrics Respiratory Drugs Sales Pneumonia , by Region Tonne (2015-2020)
  • Table 138. Pediatrics Respiratory Drugs Sales Tuberculosis , by Region Tonne (2015-2020)
  • Table 139. Pediatrics Respiratory Drugs Sales Others , by Region Tonne (2015-2020)
  • Table 140. Pediatrics Respiratory Drugs Sales: by Distribution Channel(Tonne)
  • Table 141. Pediatrics Respiratory Drugs Sales Hospitals & Clinics , by Region Tonne (2015-2020)
  • Table 142. Pediatrics Respiratory Drugs Sales Retail Pharmacies , by Region Tonne (2015-2020)
  • Table 143. Pediatrics Respiratory Drugs Sales Online Pharmacies , by Region Tonne (2015-2020)
  • Table 144. Pediatrics Respiratory Drugs Sales: by Form(Tonne)
  • Table 145. Pediatrics Respiratory Drugs Sales Tablets , by Region Tonne (2015-2020)
  • Table 146. Pediatrics Respiratory Drugs Sales Powder , by Region Tonne (2015-2020)
  • Table 147. Pediatrics Respiratory Drugs Sales Injection , by Region Tonne (2015-2020)
  • Table 148. Pediatrics Respiratory Drugs Sales Others , by Region Tonne (2015-2020)
  • Table 149. Pediatrics Respiratory Drugs Sales: by Drug Class(Tonne)
  • Table 150. Pediatrics Respiratory Drugs Sales Anti-Inflammatory Drugs , by Region Tonne (2015-2020)
  • Table 151. Pediatrics Respiratory Drugs Sales Bronchodilators , by Region Tonne (2015-2020)
  • Table 152. Pediatrics Respiratory Drugs Sales Combination Drugs , by Region Tonne (2015-2020)
  • Table 153. Pediatrics Respiratory Drugs Sales Corticosteroid , by Region Tonne (2015-2020)
  • Table 154. Pediatrics Respiratory Drugs Sales Monoclonal Antibodies , by Region Tonne (2015-2020)
  • Table 155. Pediatrics Respiratory Drugs Sales Others , by Region Tonne (2015-2020)
  • Table 156. South America Pediatrics Respiratory Drugs Sales, by Country Tonne (2015-2020)
  • Table 157. South America Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 158. South America Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 159. South America Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 160. South America Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 161. Brazil Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 162. Brazil Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 163. Brazil Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 164. Brazil Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 165. Argentina Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 166. Argentina Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 167. Argentina Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 168. Argentina Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 169. Rest of South America Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 170. Rest of South America Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 171. Rest of South America Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 172. Rest of South America Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 173. Asia Pacific Pediatrics Respiratory Drugs Sales, by Country Tonne (2015-2020)
  • Table 174. Asia Pacific Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 175. Asia Pacific Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 176. Asia Pacific Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 177. Asia Pacific Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 178. China Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 179. China Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 180. China Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 181. China Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 182. Japan Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 183. Japan Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 184. Japan Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 185. Japan Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 186. India Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 187. India Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 188. India Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 189. India Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 190. South Korea Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 191. South Korea Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 192. South Korea Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 193. South Korea Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 194. Taiwan Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 195. Taiwan Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 196. Taiwan Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 197. Taiwan Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 198. Australia Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 199. Australia Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 200. Australia Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 201. Australia Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 202. Rest of Asia-Pacific Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 203. Rest of Asia-Pacific Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 204. Rest of Asia-Pacific Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 205. Rest of Asia-Pacific Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 206. Europe Pediatrics Respiratory Drugs Sales, by Country Tonne (2015-2020)
  • Table 207. Europe Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 208. Europe Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 209. Europe Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 210. Europe Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 211. Germany Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 212. Germany Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 213. Germany Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 214. Germany Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 215. France Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 216. France Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 217. France Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 218. France Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 219. Italy Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 220. Italy Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 221. Italy Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 222. Italy Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 223. United Kingdom Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 224. United Kingdom Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 225. United Kingdom Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 226. United Kingdom Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 227. Netherlands Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 228. Netherlands Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 229. Netherlands Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 230. Netherlands Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 231. Rest of Europe Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 232. Rest of Europe Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 233. Rest of Europe Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 234. Rest of Europe Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 235. MEA Pediatrics Respiratory Drugs Sales, by Country Tonne (2015-2020)
  • Table 236. MEA Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 237. MEA Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 238. MEA Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 239. MEA Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 240. Middle East Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 241. Middle East Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 242. Middle East Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 243. Middle East Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 244. Africa Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 245. Africa Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 246. Africa Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 247. Africa Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 248. North America Pediatrics Respiratory Drugs Sales, by Country Tonne (2015-2020)
  • Table 249. North America Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 250. North America Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 251. North America Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 252. North America Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 253. United States Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 254. United States Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 255. United States Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 256. United States Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 257. Canada Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 258. Canada Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 259. Canada Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 260. Canada Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 261. Mexico Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2015-2020)
  • Table 262. Mexico Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2015-2020)
  • Table 263. Mexico Pediatrics Respiratory Drugs Sales, by Form Tonne (2015-2020)
  • Table 264. Mexico Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2015-2020)
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Company Basic Information, Sales Area and Its Competitors
  • Table 272. Company Basic Information, Sales Area and Its Competitors
  • Table 273. Company Basic Information, Sales Area and Its Competitors
  • Table 274. Company Basic Information, Sales Area and Its Competitors
  • Table 275. Company Basic Information, Sales Area and Its Competitors
  • Table 276. Pediatrics Respiratory Drugs: by Disease Type(USD Million)
  • Table 277. Pediatrics Respiratory Drugs Asthma , by Region USD Million (2021-2026)
  • Table 278. Pediatrics Respiratory Drugs Cystic Fibrosis , by Region USD Million (2021-2026)
  • Table 279. Pediatrics Respiratory Drugs Bronchiolitis , by Region USD Million (2021-2026)
  • Table 280. Pediatrics Respiratory Drugs Pneumonia , by Region USD Million (2021-2026)
  • Table 281. Pediatrics Respiratory Drugs Tuberculosis , by Region USD Million (2021-2026)
  • Table 282. Pediatrics Respiratory Drugs Others , by Region USD Million (2021-2026)
  • Table 283. Pediatrics Respiratory Drugs: by Distribution Channel(USD Million)
  • Table 284. Pediatrics Respiratory Drugs Hospitals & Clinics , by Region USD Million (2021-2026)
  • Table 285. Pediatrics Respiratory Drugs Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 286. Pediatrics Respiratory Drugs Online Pharmacies , by Region USD Million (2021-2026)
  • Table 287. Pediatrics Respiratory Drugs: by Form(USD Million)
  • Table 288. Pediatrics Respiratory Drugs Tablets , by Region USD Million (2021-2026)
  • Table 289. Pediatrics Respiratory Drugs Powder , by Region USD Million (2021-2026)
  • Table 290. Pediatrics Respiratory Drugs Injection , by Region USD Million (2021-2026)
  • Table 291. Pediatrics Respiratory Drugs Others , by Region USD Million (2021-2026)
  • Table 292. Pediatrics Respiratory Drugs: by Drug Class(USD Million)
  • Table 293. Pediatrics Respiratory Drugs Anti-Inflammatory Drugs , by Region USD Million (2021-2026)
  • Table 294. Pediatrics Respiratory Drugs Bronchodilators , by Region USD Million (2021-2026)
  • Table 295. Pediatrics Respiratory Drugs Combination Drugs , by Region USD Million (2021-2026)
  • Table 296. Pediatrics Respiratory Drugs Corticosteroid , by Region USD Million (2021-2026)
  • Table 297. Pediatrics Respiratory Drugs Monoclonal Antibodies , by Region USD Million (2021-2026)
  • Table 298. Pediatrics Respiratory Drugs Others , by Region USD Million (2021-2026)
  • Table 299. South America Pediatrics Respiratory Drugs, by Country USD Million (2021-2026)
  • Table 300. South America Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 301. South America Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 302. South America Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 303. South America Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 304. Brazil Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 305. Brazil Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 306. Brazil Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 307. Brazil Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 308. Argentina Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 309. Argentina Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 310. Argentina Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 311. Argentina Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 312. Rest of South America Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 313. Rest of South America Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 314. Rest of South America Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 315. Rest of South America Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 316. Asia Pacific Pediatrics Respiratory Drugs, by Country USD Million (2021-2026)
  • Table 317. Asia Pacific Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 318. Asia Pacific Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 319. Asia Pacific Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 320. Asia Pacific Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 321. China Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 322. China Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 323. China Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 324. China Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 325. Japan Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 326. Japan Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 327. Japan Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 328. Japan Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 329. India Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 330. India Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 331. India Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 332. India Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 333. South Korea Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 334. South Korea Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 335. South Korea Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 336. South Korea Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 337. Taiwan Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 338. Taiwan Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 339. Taiwan Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 340. Taiwan Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 341. Australia Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 342. Australia Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 343. Australia Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 344. Australia Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 345. Rest of Asia-Pacific Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 346. Rest of Asia-Pacific Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 347. Rest of Asia-Pacific Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 348. Rest of Asia-Pacific Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 349. Europe Pediatrics Respiratory Drugs, by Country USD Million (2021-2026)
  • Table 350. Europe Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 351. Europe Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 352. Europe Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 353. Europe Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 354. Germany Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 355. Germany Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 356. Germany Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 357. Germany Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 358. France Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 359. France Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 360. France Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 361. France Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 362. Italy Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 363. Italy Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 364. Italy Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 365. Italy Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 366. United Kingdom Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 367. United Kingdom Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 368. United Kingdom Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 369. United Kingdom Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 370. Netherlands Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 371. Netherlands Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 372. Netherlands Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 373. Netherlands Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 374. Rest of Europe Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 375. Rest of Europe Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 376. Rest of Europe Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 377. Rest of Europe Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 378. MEA Pediatrics Respiratory Drugs, by Country USD Million (2021-2026)
  • Table 379. MEA Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 380. MEA Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 381. MEA Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 382. MEA Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 383. Middle East Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 384. Middle East Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 385. Middle East Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 386. Middle East Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 387. Africa Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 388. Africa Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 389. Africa Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 390. Africa Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 391. North America Pediatrics Respiratory Drugs, by Country USD Million (2021-2026)
  • Table 392. North America Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 393. North America Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 394. North America Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 395. North America Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 396. United States Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 397. United States Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 398. United States Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 399. United States Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 400. Canada Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 401. Canada Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 402. Canada Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 403. Canada Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 404. Mexico Pediatrics Respiratory Drugs, by Disease Type USD Million (2021-2026)
  • Table 405. Mexico Pediatrics Respiratory Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 406. Mexico Pediatrics Respiratory Drugs, by Form USD Million (2021-2026)
  • Table 407. Mexico Pediatrics Respiratory Drugs, by Drug Class USD Million (2021-2026)
  • Table 408. Pediatrics Respiratory Drugs Sales: by Disease Type(Tonne)
  • Table 409. Pediatrics Respiratory Drugs Sales Asthma , by Region Tonne (2021-2026)
  • Table 410. Pediatrics Respiratory Drugs Sales Cystic Fibrosis , by Region Tonne (2021-2026)
  • Table 411. Pediatrics Respiratory Drugs Sales Bronchiolitis , by Region Tonne (2021-2026)
  • Table 412. Pediatrics Respiratory Drugs Sales Pneumonia , by Region Tonne (2021-2026)
  • Table 413. Pediatrics Respiratory Drugs Sales Tuberculosis , by Region Tonne (2021-2026)
  • Table 414. Pediatrics Respiratory Drugs Sales Others , by Region Tonne (2021-2026)
  • Table 415. Pediatrics Respiratory Drugs Sales: by Distribution Channel(Tonne)
  • Table 416. Pediatrics Respiratory Drugs Sales Hospitals & Clinics , by Region Tonne (2021-2026)
  • Table 417. Pediatrics Respiratory Drugs Sales Retail Pharmacies , by Region Tonne (2021-2026)
  • Table 418. Pediatrics Respiratory Drugs Sales Online Pharmacies , by Region Tonne (2021-2026)
  • Table 419. Pediatrics Respiratory Drugs Sales: by Form(Tonne)
  • Table 420. Pediatrics Respiratory Drugs Sales Tablets , by Region Tonne (2021-2026)
  • Table 421. Pediatrics Respiratory Drugs Sales Powder , by Region Tonne (2021-2026)
  • Table 422. Pediatrics Respiratory Drugs Sales Injection , by Region Tonne (2021-2026)
  • Table 423. Pediatrics Respiratory Drugs Sales Others , by Region Tonne (2021-2026)
  • Table 424. Pediatrics Respiratory Drugs Sales: by Drug Class(Tonne)
  • Table 425. Pediatrics Respiratory Drugs Sales Anti-Inflammatory Drugs , by Region Tonne (2021-2026)
  • Table 426. Pediatrics Respiratory Drugs Sales Bronchodilators , by Region Tonne (2021-2026)
  • Table 427. Pediatrics Respiratory Drugs Sales Combination Drugs , by Region Tonne (2021-2026)
  • Table 428. Pediatrics Respiratory Drugs Sales Corticosteroid , by Region Tonne (2021-2026)
  • Table 429. Pediatrics Respiratory Drugs Sales Monoclonal Antibodies , by Region Tonne (2021-2026)
  • Table 430. Pediatrics Respiratory Drugs Sales Others , by Region Tonne (2021-2026)
  • Table 431. South America Pediatrics Respiratory Drugs Sales, by Country Tonne (2021-2026)
  • Table 432. South America Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 433. South America Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 434. South America Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 435. South America Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 436. Brazil Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 437. Brazil Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 438. Brazil Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 439. Brazil Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 440. Argentina Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 441. Argentina Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 442. Argentina Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 443. Argentina Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 444. Rest of South America Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 445. Rest of South America Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 446. Rest of South America Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 447. Rest of South America Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 448. Asia Pacific Pediatrics Respiratory Drugs Sales, by Country Tonne (2021-2026)
  • Table 449. Asia Pacific Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 450. Asia Pacific Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 451. Asia Pacific Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 452. Asia Pacific Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 453. China Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 454. China Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 455. China Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 456. China Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 457. Japan Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 458. Japan Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 459. Japan Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 460. Japan Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 461. India Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 462. India Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 463. India Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 464. India Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 465. South Korea Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 466. South Korea Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 467. South Korea Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 468. South Korea Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 469. Taiwan Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 470. Taiwan Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 471. Taiwan Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 472. Taiwan Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 473. Australia Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 474. Australia Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 475. Australia Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 476. Australia Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 477. Rest of Asia-Pacific Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 478. Rest of Asia-Pacific Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 479. Rest of Asia-Pacific Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 480. Rest of Asia-Pacific Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 481. Europe Pediatrics Respiratory Drugs Sales, by Country Tonne (2021-2026)
  • Table 482. Europe Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 483. Europe Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 484. Europe Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 485. Europe Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 486. Germany Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 487. Germany Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 488. Germany Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 489. Germany Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 490. France Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 491. France Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 492. France Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 493. France Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 494. Italy Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 495. Italy Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 496. Italy Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 497. Italy Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 498. United Kingdom Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 499. United Kingdom Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 500. United Kingdom Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 501. United Kingdom Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 502. Netherlands Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 503. Netherlands Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 504. Netherlands Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 505. Netherlands Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 506. Rest of Europe Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 507. Rest of Europe Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 508. Rest of Europe Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 509. Rest of Europe Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 510. MEA Pediatrics Respiratory Drugs Sales, by Country Tonne (2021-2026)
  • Table 511. MEA Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 512. MEA Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 513. MEA Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 514. MEA Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 515. Middle East Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 516. Middle East Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 517. Middle East Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 518. Middle East Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 519. Africa Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 520. Africa Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 521. Africa Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 522. Africa Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 523. North America Pediatrics Respiratory Drugs Sales, by Country Tonne (2021-2026)
  • Table 524. North America Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 525. North America Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 526. North America Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 527. North America Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 528. United States Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 529. United States Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 530. United States Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 531. United States Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 532. Canada Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 533. Canada Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 534. Canada Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 535. Canada Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 536. Mexico Pediatrics Respiratory Drugs Sales, by Disease Type Tonne (2021-2026)
  • Table 537. Mexico Pediatrics Respiratory Drugs Sales, by Distribution Channel Tonne (2021-2026)
  • Table 538. Mexico Pediatrics Respiratory Drugs Sales, by Form Tonne (2021-2026)
  • Table 539. Mexico Pediatrics Respiratory Drugs Sales, by Drug Class Tonne (2021-2026)
  • Table 540. Research Programs/Design for This Report
  • Table 541. Key Data Information from Secondary Sources
  • Table 542. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pediatrics Respiratory Drugs: by Disease Type USD Million (2015-2020)
  • Figure 5. Global Pediatrics Respiratory Drugs: by Distribution Channel USD Million (2015-2020)
  • Figure 6. Global Pediatrics Respiratory Drugs: by Form USD Million (2015-2020)
  • Figure 7. Global Pediatrics Respiratory Drugs: by Drug Class USD Million (2015-2020)
  • Figure 8. South America Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 9. Asia Pacific Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 10. Europe Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 11. MEA Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 12. North America Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 13. Global Pediatrics Respiratory Drugs: by Disease Type Tonne (2015-2020)
  • Figure 14. Global Pediatrics Respiratory Drugs: by Distribution Channel Tonne (2015-2020)
  • Figure 15. Global Pediatrics Respiratory Drugs: by Form Tonne (2015-2020)
  • Figure 16. Global Pediatrics Respiratory Drugs: by Drug Class Tonne (2015-2020)
  • Figure 17. South America Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 18. Asia Pacific Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 19. Europe Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 20. MEA Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 21. North America Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 22. Global Pediatrics Respiratory Drugs share by Players 2020 (%)
  • Figure 23. Global Pediatrics Respiratory Drugs share by Players (Top 3) 2020(%)
  • Figure 24. Global Pediatrics Respiratory Drugs share by Players (Top 5) 2020(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 27. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 28. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Bayer (Germany) Revenue: by Geography 2020
  • Figure 30. Eli Lilly (United States) Revenue, Net Income and Gross profit
  • Figure 31. Eli Lilly (United States) Revenue: by Geography 2020
  • Figure 32. Forest Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 33. Forest Laboratories (United States) Revenue: by Geography 2020
  • Figure 34. AstraZeneca plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. AstraZeneca plc (United Kingdom) Revenue: by Geography 2020
  • Figure 36. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 37. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2020
  • Figure 38. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 39. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 40. Novartis Pharmaceuticals (Switzerland) Revenue, Net Income and Gross profit
  • Figure 41. Novartis Pharmaceuticals (Switzerland) Revenue: by Geography 2020
  • Figure 42. Novo Nordisk (Denmark) Revenue, Net Income and Gross profit
  • Figure 43. Novo Nordisk (Denmark) Revenue: by Geography 2020
  • Figure 44. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 45. Merck (United States) Revenue: by Geography 2020
  • Figure 46. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 47. Pfizer (United States) Revenue: by Geography 2020
  • Figure 48. Global Pediatrics Respiratory Drugs: by Disease Type USD Million (2021-2026)
  • Figure 49. Global Pediatrics Respiratory Drugs: by Distribution Channel USD Million (2021-2026)
  • Figure 50. Global Pediatrics Respiratory Drugs: by Form USD Million (2021-2026)
  • Figure 51. Global Pediatrics Respiratory Drugs: by Drug Class USD Million (2021-2026)
  • Figure 52. South America Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 53. Asia Pacific Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 54. Europe Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 55. MEA Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 56. North America Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 57. Global Pediatrics Respiratory Drugs: by Disease Type Tonne (2021-2026)
  • Figure 58. Global Pediatrics Respiratory Drugs: by Distribution Channel Tonne (2021-2026)
  • Figure 59. Global Pediatrics Respiratory Drugs: by Form Tonne (2021-2026)
  • Figure 60. Global Pediatrics Respiratory Drugs: by Drug Class Tonne (2021-2026)
  • Figure 61. South America Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 62. Asia Pacific Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 63. Europe Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 64. MEA Pediatrics Respiratory Drugs Share (%), by Country
  • Figure 65. North America Pediatrics Respiratory Drugs Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Abbott Laboratories (United States)
  • Bayer (Germany)
  • Eli Lilly (United States)
  • Forest Laboratories (United States)
  • AstraZeneca plc (United Kingdom)
  • GlaxoSmithKline (United Kingdom)
  • Johnson & Johnson (United States)
  • Novartis Pharmaceuticals (Switzerland)
  • Novo Nordisk (Denmark)
  • Merck (United States)
  • Pfizer (United States)
Additional players considered in the study are as follows:
F. Hoffmann-La Roche AG (Switzerland) , Regeneron Pharmaceuticals (United States) , Boehringer Ingelheim (Germany) , MedImmune (United States) , Zambon (Italy) , Genentech (United States) , Colgate Oral Pharmaceuticals (United States) , Bristol-Myers Squibb (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation